Cervical cancer is the fourth most common malignancy in females worldwide, and a leading
cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Cervical cancer prevention is based on primary prevention with vaccines against Human
Papillomavirus (HPV) and secondary prevention by screening with High‐Risk‐HPV (Hr …

Cervical cancer screening (CCS) has been proven to reducing mortality of cervical cancer;
yet migrant women show a lower participation in screening compared to non-migrants. This …

Abstract High-Risk Human papillomavirus (HR-HPV) full genotyping methods have been
described as of great potential use in epidemiology and preventive strategies, including …

Background Cervical cancer is the fourth most frequently diagnosed and found to be the
leading cause of cancer death in women, especially in low and middle-income countries …

An important component of cancer control programs for the growing burden in sub-Saharan
Africa is a population's awareness of risk factors. Studies thereof have focused on single …

Purpose The lack of prognostic data impedes implementation of optimal therapy for cervical
cancer. For instance, recommended therapy for FIGO IIB cervical cancer is radical …

Background The aim of this study was to investigate time trends in cervical cancer mortality
rates in Lithuania across age groups and time periods over a 30-year time span. Methods …

Background Cervical cancer is the fourth highest incidence of malignancy in the world and a
common cause of cancer death in women. We assessed the trends of incidence and …